NVIDIA Opens BioNeMo to Scale Digital Biology for Global Biopharma and Scientific Industry

NVIDIA today announced that global pharmaceutical and techbio industry leaders, academic pioneers and AI researchers are adopting the open-source NVIDIA® BioNeMo™ Framework to advance drug discovery and accelerate molecule design.